Price
54.39
-1.06%52W Range
Market Cap
₹167.44 Cr
Traded: ₹0.13 Cr (0.08%) 0.0x
Free Float: ₹86.13 Cr (0.16% of FF traded)
Volume · 60D trend
24.63 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +5.0% | +0.0% | -8.0% | -- | +9.0% | Stable |
| Profit | -25.0% | -49.0% | -61.0% | -- | -83.0% | Decelerating |
| Return | -8.0% | -14.0% | -19.0% | -33.0% | -- | Decelerating |
| ROE | +6.0% | +3.0% | +2.0% | -- | -- | Decelerating |
Quarterly Results
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 252 | 258 | 242 | 225 | 240 | 207 | 208 | 242 | 334 | 307 | 316 | 323 | 324 | 340 | 324 |
| Expenses | 248 | 258 | 240 | 227 | 234 | 207 | 203 | 232 | 317 | 323 | 300 | 305 | 316 | 317 | 307 |
| Operating Profit | 4 | 0 | 2 | -2 | 6 | -1 | 4 | 9 | 17 | -17 | 16 | 18 | 8 | 23 | 17 |
| OPM % | 1.4% | 0.1% | 0.9% | -1.0% | 2.3% | -0.3% | 2.1% | 3.9% | 5.2% | -5.4% | 5.1% | 5.5% | 2.5% | 6.7% | 5.3% |
| Other Income | 4 | 3 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 2 | 3 | 3 | 2 | 2 | 1 |
| Interest | 1 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit Before Tax | 6 | 2 | 5 | 1 | 6 | 2 | 6 | 12 | 18 | -16 | 17 | 19 | 8 | 23 | 16 |
| Tax % | 89.8% | 57.1% | -10.9% | 940.0% | 59.7% | 49.8% | 93.8% | 35.9% | -5.3% | 37.9% | 37.2% | 35.8% | 67.4% | 32.9% | 33.2% |
| Net Profit | 1 | 1 | 5 | -5 | 3 | 1 | 0 | 8 | 19 | -22 | 11 | 12 | 3 | 15 | 11 |
| Exceptional Items | -0 | -2 | -0 | -0 | -0 | 0 | -2 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 0.2 | 0.2 | 1.7 | -1.5 | 0.8 | 0.4 | 0.1 | 2.5 | 6.2 | -7.2 | 3.5 | 3.9 | 0.8 | 5.0 | 3.5 |
| Sales Growth (YoY) | 5.1% | 24.8% | 16.4% | -7.2% | -28.3% | -32.6% | -34.3% | -25.0% | 3.1% | -9.7% | -2.3% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -2.4% | 6.7% | 7.8% | -6.3% | 15.9% | -0.5% | -14.1% | -27.6% | 8.9% | -2.9% | -2.0% | -0.5% | -4.6% | 5.0% | -- |
| OP Growth (YoY) | -34.8% | 123.8% | -49.8% | -124.5% | -68.3% | 96.2% | -73.0% | -46.5% | 117.8% | -173.0% | -5.6% | -- | -- | -- | -- |
| OP Growth (QoQ) | 2293.3% | -93.2% | 194.4% | -142.1% | 974.6% | -114.4% | -54.0% | -45.4% | 205.1% | -202.2% | -8.7% | 122.1% | -64.8% | 32.2% | -- |
| Profit Growth (YoY) | -77.0% | 26.0% | 425.0% | -156.0% | -85.0% | 106.0% | -91.0% | -35.0% | 633.0% | -244.0% | 0.0% | 104.0% | -30.0% | 65.3% | -9.0% |
| EPS Growth (YoY) | -75.9% | -45.0% | 1325.0% | -160.7% | -86.5% | 105.6% | -96.6% | -37.1% | 634.5% | -243.6% | 0.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -9.1% | -87.1% | 214.0% | -280.7% | 107.5% | 233.3% | -95.1% | -60.0% | 186.3% | -302.6% | -10.2% | 367.9% | -83.1% | 41.9% | -- |
| OP Margin | 1.4% | 0.1% | 0.9% | -1.0% | 2.3% | -0.3% | 2.1% | 3.9% | 5.2% | -5.4% | 5.1% | 5.5% | 2.5% | 6.7% | 5.3% |
| Net Margin | 0.3% | 0.3% | 2.2% | -2.0% | 1.1% | 0.6% | 0.2% | 3.1% | 5.7% | -7.2% | 3.4% | 3.8% | 0.8% | 4.5% | 3.3% |
| Material Cost % | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.3% | 0.2% | 0.0% | 4.2% | 0.0% | 0.0% | 0.6% | 0.1% | 4.3% | 6.0% |
| Employee Cost % | 48.7% | 47.6% | 51.1% | 53.7% | 51.4% | 53.3% | 51.0% | 59.2% | 54.9% | 66.3% | 64.5% | 64.7% | 67.0% | 60.5% | 61.0% |
| P/S | 0.17 | 0.18 | 0.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 86.33 | 44.79 | 36.19 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 0.21 | 0.23 | 0.21 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Please find attached herewith Copy of Newspaper Publication
Please find attached herewith the disclosure regarding the Appointment of Mr. Narendra Bhandari as an Independent Director subject to the approval of shareholders of the company for the ....
Please find attached herewith Press Release announcement under Regulation 30 for the Quarter Ended June 30, 2027
Please find attached herewith Unaudited Consolidated and Standalone Financial Results for Quarter Ended June 2026
Outcome of Board Meeting
Trigyn Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited (Standalone and ....
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation for the Quarter ended 30 June, 2026
Please find enclosed herewith copies of the newspaper publication pertaining to the notice of of shareholders regarding the proposed transfer of equity shares and unclaimed dividend to ....
Closure of Trading Window for declaration of unaudited financial Results for the Quarter ended June 30,2026
Please find attached Scrutinizer ''Report
Please find attached outcome of the Postal ballot along with Scrutinizer Report
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Please find attached Annual Secretarial Compliance Report for the Financial Year Ended 31 March, 2026
Please find attached copy of newspaper publication
Please find attached copy of newspaper publication for Financial Results
Please find attached calendar of Events for the Postal Ballot
Please find attached Notice of Postal Ballot
Outcome of the Board Meeting Along with Financial Results for the Quarter and Year Ended March, 31 2026 and Auditors Report thereon
Please find attached herewith financial results for the Quarter and Year Ended March 31,2026
Please find attached Press Release
Trigyn Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Audited (Standalone and ....
Please find attached herewith the Clarification on Price Movement
The Exchange has sought clarification from Trigyn Technologies Ltd on April 24, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Certificate under Reg.74 (5) of SEBI (DP) Regulations, 2018 for Quarter ended March 31, 2026.
The trading window for dealing in Securities of the Company will remain closed from April 01, 2026, till 48 hours after the declaration of audited standalone and consolidated financial ....
Please find attached herewith a copy of resignation of Dr Satyam Cherukuri from the position of Chairman and Non Executive Director wef April 07,2026
Please find attached herewith the resignation of Dr Satyam Cherukuri as Chairman and Non-Executive Director of the Company wef April 07,2026
Please find attached copy of newspaper publication
Board Meeting Outcome for Financial Results for the quarter and nine-month period ended December 31, 2025.
Please find attached herewith Financial Results for the Third Quarter and Nine Month Period Ended December 31,2025
Please find attached herewith copy of press release
Newspaper Publication w.r.t SEBI Circular on Special Window for re-lodgment of transfer request of physical shares.
Trigyn Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
Please find attached herewith Certificate Reg. 74(5) of SEBI (DP) Regulations,2018
Intimation of Closure of Trading Window from Thursday January 01, 2026, to till 48hours after the declaration of Unaudited Financial Results of the Company for the Quarter Ending December 31, 2025
Cessation of Mr. Vikram Chandna as Chief Executive Officer (CEO) w.e.f November 21, 2025
Please find attached herewith Newspaper Publication
Outcome of Board Meeting
Refer Attached
Trigyn Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Please find attached herewith copy of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Voting Results and Scrutinizer Report - 39th AGM
AGM Proceedings
Please refer attached
Please find attached herewith intimation of Closure of Trading Window for the Quarter and Nine month ended September 30, 2025.
Please find attached herewith copy of Newspaper Publication
Please find attached herewith the clarification on Price Movement.
The Exchange has sought clarification from Trigyn Technologies Ltd on September 23, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
We hereby inform you that the Company has submitted a revised newspaper publication regarding completion of dispatch of Notice of 39th Annual General Meeting, as the publication in Business ....
Please find attached herewith Copy of Newspaper Publication for Completion of dispatch of Notice of 39th Annual General Meeting (AGM).
Annual Reports
14